Case Study
Imperial’s end-to-end supply chain solution boosts Bausch & Lomb"s sales and service levels
• 03 June 2019, 19:17 IPL 5 710c -308c (-5.12%) Best Bid: 5 650c Best Offer: 5 950c Imperial’s end-to-end supply chain solution boosts Bausch & Lomb"s sales and service levels 11 March 2016 When Imperial Heath Sciences client Valeant Pharmaceuticals International acquired vision care company Bausch & Lomb, it was faced with the complex challenges that mark this testing pharmaceutical category. Bausch & Lomb’s product range includes contact lenses that are distributed through optometrists; lens care and solutions that are sold through retailers and pharmacies; and surgical products and equipment, including intraocular lens implants. The Problem Valeant initially placed its South African division of Bausch & Lomb into the Linbro Park facility of local subsidiary, iNova. Focused on devel